Preference of Oral Tenofovir Disoproxil Fumarate/Emtricitabine Versus Rectal Tenofovir Reduced-Glycerin 1% Gel Regimens for HIV Prevention Among Cisgender Men and Transgender Women Who Engage in Receptive Anal Intercourse with Men
© 2017, Springer Science+Business Media, LLC, part of Springer Nature. Oral pre-exposure prophylaxis (PrEP) can prevent HIV transmission. Yet, some may prefer not to take systemic daily medication. MTN-017 was a 3-period, phase 2 safety and acceptability study of microbicide gel applied rectally eit...
Saved in:
Main Authors: | Alex Carballo-Diéguez, Rebecca Giguere, Curtis Dolezal, Cheng Shiun Leu, Iván C. Balán, William Brown, Christine Rael, Barbra A. Richardson, Jeanna M. Piper, Linda Gail Bekker, Suwat Chariyalertsak, Anupong Chitwarakorn, Pedro Gonzales, Timothy H. Holtz, Albert Liu, Kenneth H. Mayer, Carmen D. Zorrilla, Javier R. Lama, Ian McGowan, Ross D. Cranston |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85033365678&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/43464 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Preference of Oral Tenofovir Disoproxil Fumarate/Emtricitabine Versus Rectal Tenofovir Reduced-Glycerin 1% Gel Regimens for HIV Prevention Among Cisgender Men and Transgender Women Who Engage in Receptive Anal Intercourse with Men
by: Alex Carballo-Diéguez, et al.
Published: (2018) -
Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men
by: Peter L. Anderson, et al.
Published: (2018) -
Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men
by: Anderson P., et al.
Published: (2017) -
MTN-017: A rectal phase 2 extended safety and acceptability study of tenofovir reduced-glycerin 1% gel
by: Cranston R., et al.
Published: (2017) -
MTN-017: A rectal phase 2 extended safety and acceptability study of tenofovir reduced-glycerin 1% gel
by: Ross D. Cranston, et al.
Published: (2018)